BGM Group (BGM) Stock Price, News & Analysis

Company Overview

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

Key Stats

• Today's Range: $7.42 to $7.83
• 50-Day Range: $7.44 to $13.00
• 52-Week Range: $6.05 to $17.17
• Volume: 9,749 shs
• Average Volume: 46,843 shs
• Market Capitalization: $732.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BGM Stock Analysis - Frequently Asked Questions

How have BGM shares performed this year?

BGM Group's stock was trading at $8.45 at the start of the year. Since then, BGM stock has decreased by 9.9% and is now trading at $7.61.

Who are BGM Group's major shareholders?

Top institutional shareholders of BGM Group include Geode Capital Management LLC (0.04%) and Marshall Wace LLP (0.02%).

How do I buy shares of BGM Group?

Shares of BGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BGM Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BGM Group investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

• Today: 9/03/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:BGM
• Previous Symbol: NASDAQ:BGM
• CIK: 1779578
• Web: www.qlsyy.net
• Phone: 86-02-8647-75180
• Fax: N/A
• Employees: 298
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.82
• Quick Ratio: 1.45

Sales & Book Value

• Annual Sales: $25.10 million
• Price / Sales: 30.04
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7.34 per share
• Price / Book: 1.06

Miscellaneous

• Outstanding Shares: 97,220,000
• Free Float: 40,192,000
• Market Cap: $753.94 million
• Optionable: N/A
• Beta: 1.26